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Abstract
Background: Studies of the bacterial communities of the gut microbiota have revealed a shift in the ratio of Firmicutes and
Bacteroidetes in obese patients. Determining the variations of microbial communities in feces may be beneficial for the
identification of specific profiles in patients with abnormal weights. The roles of the archaeon Methanobrevibacter smithii
and Lactobacillus species have not been described in these studies.
Methods and Findings: We developed an efficient and robust real-time PCR tool that includes a plasmid-based internal
control and allows for quantification of the bacterial divisions Bacteroidetes, Firmicutes, and Lactobacillus as well as the
methanogen M. smithii. We applied this technique to the feces of 20 obese subjects, 9 patients with anorexia nervosa, and
20 normal-weight healthy controls. Our results confirmed a reduction in the Bacteroidetes community in obese patients
(p,0.01). We found a significantly higher Lactobacillus species concentration in obese patients than in lean controls
(p=0.0197) or anorexic patients (p=0.0332). The M. smithii concentration was much higher in anorexic patients than in the
lean population (p=0.0171).
Conclusions: Lactobacillus species are widely used as growth promoters in the farm industry and are now linked to obesity
in humans. The study of the bacterial flora in anorexic patients revealed an increase in M. smithii. This increase might
represent an adaptive use of nutrients in this population.
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Introduction
Obesity disorders affect many developed countries and result
from an imbalance in energy (input versus output) with serious
heath consequences, including cardiovascular disease, type II
diabetes mellitus, and colon cancer [1,2]. The role of gut
microbiota in obesity is a current public heath problem. The gut
environment likely contributes to the energy balance disequilib-
rium because of its involvement in energy intake, conversion, and
storage. The impact of the gut microbiota composition on body
weight gain or host adiposity has been supported by reports
involving mouse models with a genetic tendency for obesity [3–5].
Advances in high-throughput sequencing methods have recently
allowed for better characterization of the activities and composi-
tion of the complex gut microbial community in both healthy
patients and those in disease states [6–10]. Large-scale clonal
Sanger sequencing of the 16S rRNA genes of gut microbiota
[7,11] have contributed to our understanding of their diversity and
ecology. These methods have allowed the identification of a vast
number of new and uncultivated species [12]. A recent 16Sr RNA
sequencing-based investigation showed that the Firmicutes/Bacter-
oidetes (F/B) ratio differed in obese and lean human subjects,
mainly due to a reduced Bacteroidetes proportion in obese subjects.
This finding was unexpected, because the Bacteroidetes member
Bacteroides thetaiotaomicron is associated with host adiposity [3]. Using
a weight loss program, Ley and colleagues [7] demonstrated that a
decrease in the F/B ratio in obese individuals correlated with
weight loss over time and suggested that modulating the
abundance of specific bacterial communities might be beneficial
in the treatment of obesity. The growth promoters such as
Lactobacillus species could be one of these specific bacterial
communities since its impact on food conversion and weight gain
has been demonstrated in farm animals [13].
The characterization and the relative abundance of higher
taxonomic orders of gut microbiota have been investigated using
multiple methods, including metagenomics, microarrays, and
sequencing of large clone libraries. Although these methods are
powerful in terms of data production, they involve time-
consuming, costly, and tedious data analysis.
In the present work, we identified and used the genomic
signature of Lactobacillus, Methanobrevibacter smithii, Bacteroidetes, and
Firmicutes divisions. We rapidly assessed their relative abundance in
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anorexia nervosa using a real-time PCR assay. This real-time PCR
assay is a practical, low cost clinical method for monitoring the
variations of bacterial phyla of the gut. The genus, species, and
divisions we focused on may play a role in the disorder of obesity.
Methods
Bacterial Sequences and System Assessment
The sequences of archaea domain, M. smithii species, bacterial
phyla and genus were downloaded from the ribosomal database
Project II (RDP-II) using an online hierarchical browser tool.
‘‘Isolates’’ and ‘‘uncultured’’ sequences that were labeled as ‘‘good
quality’’ and had a length greater than 1,200 bp were selected.
The Firmicutes, Bacteroidetes and M. smithii systems (the nucleotide
sequence ‘‘forward primer-probe-reverse primer’’) were built as a
nucleotide pattern. The pattern was used to search against
sequences of phyla and genera using the DREG program of the
EMBOSS package.
Statistical Tests
The Bacteroidetes copy number values were converted into
logarithm values in order to equalize the standard deviations. The
normal distribution was checked using the Shapiro-Wilk test. One-
way ANOVA (P value for the Bartlett’s test) with the Tukey-
Kramer post-test was performed on the Bacteroidetes values for the
anorexic, obese, and lean groups. A Fisher exact test was
performed on a contingency table for the Lactobacillus copy
number.
An unpaired t-test was used for the comparison of M. smithii
quantification between the anorexic or the obese group and the
lean control group. The statistics were performed using GraphPad
Prism version 5 software.
Patient Recruitment
All the study was approved by the local ethics committee
‘‘Comite ´ d’e ´thique de l’IFR 48, Service de Me ´decine Le ´gale’’,
(Faculte ´d eM e ´decine, 27 Bld Jean Moulin, 13005 Marseille,
FRANCE) under the accession number Nu08-003, January the
21st, 2009. All patients were recruited at University Hospital
(CHU) of Marseille. Only verbal consent was necessary from
patients for this study. This is relied on the French bioethics decree
Nu 2007-1220 published in the official journal of the French
Republic. Normal weight control subjects were anonymously
recruited from individuals working at the laboratory (or belonging
to their family) (n=20; 13 to 68 years-old; BMI=20.68
kg/m
262.014). No several members of the same family have
been included in the study. Patients were enrolled in inpatient and
outpatient clinics at the Department of Nutrition (University
Hospital of Marseille, France). Obese patients were selected from
patients attending the clinic for surgical treatment of excessive
body weight (n=20, 17 to 72 years-old; BMI=47.09
kg/m
2610.66) and had not taken probiotics before the stool
samples were collected. Subjects with anorexia nervosa (defined by
DSM-4 criteria) were recruited from patients who were recently
hospitalized in the department (n=9, 19 to 36 years-old;
BMI=12.73 kg/m
2 61.602). The body mass index (BMI) values
were represented as mean values6SD.
Fecal DNA Isolation
Approximately 1 g of sample (two spoonfuls) was suspended in
10 ml of saline buffer and filtered into a Fecal Specimen Filtration
Vial (Orion Diagnostica–Fumouze-Division Diagnostics, Levallois
Perret, France). A total of 250 ml of the filtrate was transferred in a
sterile screw-cap Eppendorf tube containing 0.3 g acid-washed
glass beads (Sigma, Saint Quentin Fallavier, France). The tube was
shaken in a FastPrep instrument BIO 101 (Qbiogene, Strasbourg,
France) at level 6.5 (full speed) for 90 s to accomplish mechanical
lysis. The supernatant was collected and incubated overnight at
56uC with 180 ml of the T1 Buffer from NucleoSpin
H Tissue Mini
Kit (Macherey Nagel, Hoerdt, France) and 25 ml of proteinase K
(20 mg/ml). After a second cycle of mechanical lysis, the samples
were incubated for 15 min at 100uC. Next, the DNA was
extracted using the NucleoSpin
H Tissue Mini Kit according to the
manufacturer’s procedure. Finally, DNA was eluted in 100 mlo f
elution buffer and stored at 220uC until use. An extraction
negative control with 250 ml of sterile water was introduced in
each series of the DNA extraction.
Real-Time Quantitative PCR Assays
The targeted genes, probe sequences, primer sequences
(Eurogentec, Seraing, Belgium), and amplicon sizes for the two
real-time PCR assays used in this study are summarized in Table 1.
The MGB probes and primers of the Bacteroidetes and the Firmicutes
divisions were designed on the basis of the genomic DNA barcodes
previously described [14]. The probe and primers of the
Lactobacillus genus used in this study were previously reported
[15]. The M. smithii probe and primers (Table 1) were designed
using Primer3 v0.4.0 software [16]. Real-time assays were
performed in the MX3000
TM system (Stratagene Europe,
Amsterdam, The Netherlands) using the QuantiTect PCR mix
(Qiagen, Courtaboeuf, France). Included in the samples were
5 pmol of primers and probes labeled with FAM or VIC. A total of
5 ml of DNA extracted from stools or a bacterial strain was diluted
to 1/10, 1/100, or 1/1000. The dilutions were added to a final
volume of 25 ml. The real-time PCR programs for Bacteroı ¨detes
detection included 95uC for 15 min and 45 cycles (95uC3 0s ,
48uC4 5s ,7 2 uC 1 min). For Firmicutes and Lactobacillus detections,
the programs included 95uC for 15 min and 45 cycles (95uC3 0s ,
60uC 1 min). The specificity of the real-time PCR was tested
against DNA from 108 bacterial strains. The results of the
comparisons are reported in Supplementary Table S1. The
detection and quantification of Lactobacillus were performed as
previously reported [15]. The Bacteroı ¨detes and Firmicutes samples
were quantified using a quantification plasmid which was
constructed as previously described [15].
Quantification Plasmid
Chimeric fragments were used for the quantification of













The fragment length is 485 bp. The Bacteroı ¨detes targeted
sequence is in regular style, the Firmicutes targeted sequence is in
bold style, and the M. smithii targeted sequence is in underlined
style. The primer sequences are in lowercase and are underlined;
the probe sequences are in lowercase and are in italic.
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The fidelity of the DNA extraction and microbial quantifica-
tions were assessed. Three samples of feces from one obese patient
(Ob10), one anorexic patient (Ano1), and one control patient
(lean11) were defrosted. For each trial, about 1 g of fecal sample
was suspended in 5 ml of 0.05 M Tris, pH 7.3. A volume of
250 mL of the suspension was used for the DNA extraction as
described in the fecal DNA isolation section. This operation was
performed five times and generated five independent DNA
extracts per sample. Each DNA extract was tested five times by
real-time PCR to determine the quantity of Firmicutes, Bacteroidetes,
and Lactobacillus.
Results
Sensitivity and Specificity of the ‘‘Forward primer-probe-
reverse primer’’ Systems
Oligonucleotide primers and probe sequences from Bacteroidetes,
Firmicutes, Lactobacillus and M. smithii are shown in Table 1. The
sensitivity and the specificity of the Bacteroidetes, Firmicutes and M.
smithii systems were assessed in silico using the ribosomal RDP-II
database [17]. The Bacteroidetes system is highly sensitive (89.89%),
since it has a perfect match with 30,237 out of the 33,639 16S
rRNA sequences of the RDP-II Bacteroidetes phylum. The Firmicutes
system is also highly sensitive (88.94%), because it has a perfect
match with 83,576 out of 93,969 of 16S rRNA sequences of the
RDP-II Firmicutes phylum. The M. smithii system has a sensitivity of
88.89% (8 matches out of 9 sequences).
The assessment of the system’s sensitivity was refined at the
genus taxonomic level for Firmicutes and Bacteroidetes. Although
Anaerostipes is the least sensitive genus (sequence match % ,80)
with the Firmicutes system (Figure 1), the most abundant genera,
including Lachnospiraceae, Faecalibacteriun, and Subdoligranulum, are
highly detected (sequence match % .90 for each genus). The 16S
rRNA sequences of the Bacteroidetes genus were also efficiently
recovered by the Bacteroidetes system (sequence match % .90),
except for the Cytophaga genus (Figure 2).
The specificity (or the false discovery rate) of the two systems
was evaluated by looking for perfect matches with sequences
outside of the Firmicutes and Bacteroidetes phyla. Scanning all the
RDP-II 16S rRNA sequences outside of the Firmicutes or the
Bacteroidetes phyla, the false-discovery rate for the Firmicutes and
Bacteroidetes phyla is 0.83% and 0.01%, respectively. As for the
sensitivity, these results suggest a high specificity for the two
systems. Finally, the false discovery rate of the M. smithii system
reaches 0.025% for the archaea domain (2 matches out of 7,873
sequences) and is of 0% for the bacteria domain (no match out of
322,863 sequences).
Assessment of the Detection of Cultivated Strains from
Bacteroidetes and Firmicutes Phyla
A large collection of strains inhabiting the gut microbiota that
were taxonomically assigned to the Bacteroidetes and the Firmicutes
bacterial phyla were tested by real-time PCR (Supplementary
Table S1). The Bacteroidetes system (Supplementary Table S1,
column A) successfully detected all Bacteroidetes strains, including
Prevotella, Bacteroidetes, Parabacteroidetes, Captocytophaga, and Alistipes.A
few false-positives were identified, including three strains that were
assigned to the Firmicutes phylum (two Streptococcus and one
Enterococcus). However, the detection of these strains is extremely
weak due to the threshold cycle (CT) values, which were close to
40. With regard to the assessment of the Firmicutes system
(Supplementary Table S1, column B), all the Firmicutes strains
except Clostridium perfringens were identified. In addition, no false-
positive results were obtained, suggesting a high specificity for the
system. Finally, Fusobacterium strains were detected as false-positives
by the Firmicutes probe system. The detection efficiency of the
Lactobacillus system has been previously reported using a broad
range of Lactobacillus strains [15].
Bacterial Quantification of Different Human Populations
Quantification of the bacterial groups using real-time PCR was
performed on three distinct populations, including normal-weight
healthy controls (lean), patients exhibiting obesity (BMI$30
kg/m
2), and patients suffering from anorexia nervosa (defined
by DSM-4 criteria). These populations differed in terms of their
body mass indices. The bacterial quantification results for the
individuals are showed in Table 2.
The Firmicutes data was similar in the three categories (data not
shown). Compared to the lean and anorexic groups, the
Bacteroidetes data from the obese group had a smaller mean,
reduced median and smaller scatter (Figure 3). The differences in
Table 1. Bacteroidetes and Firmicutes Real-Time PCR System.
Target phylum Target gene Amplicon length (bp) Primer and probe sequences
Lactobacillus Tuf 90 FP: TACATYCCAACHCCAGAACG
RP: AAGCAACAGTACCACGACCA
Probe: AAGCCATTCTTRATGCCAGTTGAA
Firmicutes 16S rRNA 179 FP: GTCAGCTCGTGTCGTGA
RP: CCATTGTAKYACGTGTGT
Probe: GTCAANTCATCATGCC
Bacteroidetes 16S rRNA 184 FP: AGCAGCCGCGGTAAT
RP: CTAHGCATTTCACCGCTA
Probe: GGGTTTAAAGGG
M. smithii 16S rRNA 123 FP: CCGGGTATCTAATCCGGTTC
RP: CTCCCAGGGTAGAGGTGAAA
Probe: CCGTCAGAATCGTTCCAGTCAG
FP indicates the forward primer, and RP indicates the reverse primer.
doi:10.1371/journal.pone.0007125.t001
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p,0.01) or anorexic groups (*p,0.05) were statistically significant
(Figure 3). Although the average copy number of Lactobacillus was
higher in the obese group than the other groups, the difference was
not significant. However, at the individual level, the Lactobacillus
copy number was generally much greater in the obese patients
than in the lean or anorexic patients. A contingency bar graph
using a threshold of 10
6 Lactobacillus copy numbers confirmed this
observation (Figure 4). Based on this threshold, the difference in
Lactobacillus concentration was significant when obese patients
were compared with lean (p=0.0197) and anorexic (p=0.0332)
patients. The average copy number of the archaeon M. smithii is
indicated in Figure 5. The M. smithii quantification average was
slightly higher for the obese group than the lean group as indicated
by an obese/lean ratio of 1.72. In addition, the quantification
average of M. smithii for the anorexic group was much greater than
the lean and obese groups by factors of five and three, respectively.
Overall, the obese group had a bacterial profile poor in Bacteroidetes
and rich in Lactobacillus. No correlation was found between the
quantification of bacterial and archaeal groups and the diabetic
state of some obese patients. The anorexic bacterial profile is
similar to the lean control group for the Firmicutes, Bacteroidetes, and
Lactobacillus but different for M. smithii (anorexic group had higher
quantification).
Discussion
The molecular biology method developed in this study aimed to
produce a large quantity of data concerning the composition of
human gut microbiota. The data was used to analyze bacterial
community variations and their correlation with body weight.
Using in silico primers and probes designed by a pattern
identification method [14], our method utilized highly sensitive
and specific tests for Bacteroidetes and Firmicutes. In silico and
experimental tests demonstrated the efficiency of our real-time
PCR assay. To our knowledge, no such benchmarking of the
detection quality of the Firmicutes and Bacteroidetes members has
Figure 2. Bacteroidetes system sensitivity at genus taxonomic
level. Scores in parentheses indicate the number of sequences
matching the system out of the total sequence number of a given
genus.
doi:10.1371/journal.pone.0007125.g002
Figure 1. Firmicutes system sensitivity at genus taxonomic level. Scores in parentheses indicate the number of sequences matching the
system out of the total sequence number of a given genus.
doi:10.1371/journal.pone.0007125.g001
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and Bacteroidetes division and the Lactobacillus genus were amplified
and identified by our method. The system’s sensitivity and
specificity of the detection of this last bacterial group was
previously assessed by Menard et al. [15]. The reproducibility of
the quantification results obtained from the different samples
demonstrates the robustness of the extraction and quantification
steps (Table 3). The analysis of five-fold independent DNA
extracts indicated low inter-extract variability, with a coefficient
of variation ranging from 0.52 to 6.08% for Bacteroidetes,f r o m0 . 9 8
to 4.81% for Firmicutes, and from 0.64 to 2.67% for Lactobacillus
(Table 3). In addition, a quantification plasmid allowed for
quantification of the bacteria copy number. This method was
previously performed in the quantitative evaluation of bacteria
genes associated with bioterrorism [18] and vaginosis [15]. The
development of our real-time PCR system allowed us to test
similar conditions to those described by the Gordon team [4–7].
To our knowledge, our study is the largest human study
concerning obesity and gut microbiota to date. The 20 obese
Table 2. Bacteroidetes, Firmicutes, Lactobacillus and M. smithii
Quantifications.
Sample Bacteroidetes Firmicutes Lactobacillus M. smithii
Lean1 3.26E+10 4.68E+10 0.00E+00 8.16E+07
Lean2 5.08E+10 4.60E+10 0.00E+00 4.56E+08
Lean3 2.91E+10 5.40E+10 0.00E+00 1.93E+04
Lean4 1.62E+10 1.52E+10 0.00E+00 2.55E+08
Lean5 2.87E+09 9.00E+09 0.00E+00 0.00E+00
Lean6 6.12E+09 1.49E+10 0.00E+00 2.77E+03
Lean7 1.02E+10 1.45E+10 9.64E+05 6.72E+07
Lean8 6.80E+09 1.52E+10 0.00E+00 0.00E+00
Lean9 7.88E+09 1.72E+10 0.00E+00 8.80E+08
Lean10 5.20E+09 3.46E+10 5.44E+07 5.72E+02
Lean11 3.18E+10 2.15E+10 4.80E+04 7.24E+05
Lean12 1.58E+09 2.14E+09 1.08E+04 2.96E+06
Lean13 9.44E+09 1.72E+10 0.00E+00 0.00E+00
Lean14 1.67E+10 4.32E+10 0.00E+00 0.00E+00
Lean15 3.05E+10 3.37E+10 0.00E+00 2.02E+08
Lean16 2.15E+09 1.70E+10 0.00E+00 0.00E+00
Lean17 2.03E+09 4.16E+09 0.00E+00 8.64E+06
Lean18 4.72E+09 1.39E+10 0.00E+00 6.68E+02
Lean19 3.33E+09 1.06E+10 0.00E+00 2.53E+06
Lean20 2.06E+08 4.68E+08 2.37E+04 9.16E+04
Lean Mean 1.35E+10 2.16E+10 2.77E+06 9.78E+07
Ob1* 1.93E+10 3.82E+10 4.36E+08 3.62E+06
Ob2 3.85E+09 5.84E+10 3.36E+06 0.00E+00
Ob3* 1.77E+08 3.80E+09 1.29E+06 1.96E+02
Ob4 4.92E+09 9.80E+09 0.00E+00 6.16E+08
Ob5 2.01E+10 2.44E+10 0.00E+00 0.00E+00
Ob6 5.44E+08 4.44E+09 0.00E+00 5.48E+03
Ob7 1.05E+10 1.50E+10 0.00E+00 3.15E+02
Ob8 1.63E+09 6.04E+09 4.28E+07 0.00E+00
Ob9 1.94E+09 7.20E+09 3.61E+08 4.68E+03
Ob10 2.68E+08 1.14E+10 2.21E+07 0.00E+00
Ob11 9.08E+08 8.84E+09 0.00E+00 1.01E+09
Ob12 4.76E+07 2.20E+09 5.28E+06 2.76E+04
Ob13 2.14E+09 1.12E+10 0.00E+00 1.40E+04
Ob14 1.34E+08 1.30E+10 0.00E+00 6.76E+02
Ob15 6.20E+09 2.14E+10 0.00E+00 5.44E+02
Ob16 7.20E+08 2.79E+09 3.96E+06 3.88E+02
Ob17 6.60E+08 6.44E+09 0.00E+00 1.14E+03
Ob18 2.96E+08 5.52E+09 1.96E+05 1.45E+09
Ob19 3.37E+08 6.28E+09 0.00E+00 2.82E+08
Ob20 5.80E+08 1.74E+10 0.00E+00 6.96E+05
Ob Mean 3 3.76E+09 1.37E+10 4.38E+07 1.68E+08
Ano1 5.60E+08 5.44E+09 5.56E+05 5.08E+03
Ano2 4.72E+08 6.72E+09 0.00E+00 1.17E+04
Ano3 2.84E+09 1.36E+10 2.30E+04 4.48E+08
Ano4 2.44E+10 1.98E+10 0.00E+00 3.82E+08
Ano5 7.12E+09 1.42E+10 0.00E+00 3.19E+03
Ano6 3.59E+10 1.48E+10 0.00E+00 9.40E+08
Ano7 6.24E+09 1.26E+10 0.00E+00 7.12E+02
Sample Bacteroidetes Firmicutes Lactobacillus M. smithii
Ano8 1.09E+10 2.04E+10 0.00E+00 8.84E+08
Ano9 6.60E+09 7.24E+09 1.45E+05 2.08E+09
Ano Mean 1.06E+10 1.28E+10 8.04E+04 5.26E+08
Scores are bacteria/archaea copies per g of feces. Ano indicates anorexic
individuals and Ob indicates obese individuals. Lean indicates normal weight
individuals. The diabetic patients are mentioned by an asterisk (*).
doi:10.1371/journal.pone.0007125.t002
Table 2. Cont.
Figure 3. The Bacteroidetes quantification. Box and whisker: 10–90
percentiles. Outliers are plotted as a black bubble, means are plotted as
a plus, and medians are the black lines in the boxes. P value ,0.05 is
represented as * and P value ,0.01 is represented as ** on the graph.
doi:10.1371/journal.pone.0007125.g003
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by a magnitude similar to that described by Gordon [4,7]
(Figure 3; p,0.01). This comparison validates our method and
reveals that the Bacteroidetes profile of French obese patients is
similar to that of American obese patients. Nine anorexics
patients were also investigated in our study. The results of this
group were similar to the lean control group for Bacteroidetes
(Figure 3), Firmicutes (Table 2), and Lactobacillus (Table 2 and
Figure 4). A major difference was the relative increase in M. smithii
in anorexic patients compared to the lean control group (Figure 5;
p=0.0171). Accumulation of H2 in the human gut reduces the
efficiency of microbial fermentation and thereby, the yield of
energy. Methanogenic archaea are important since they are
involved in the removal of H2 excess from the human gut [19].
The most common methanogenic archaeon found in the gut
microbiota is M. smithii which can reduce CO2 with H2 to
methane. The methanogen identification by cultivation based
studies (in human faeces) has been hampered by the strict
anaerobic nature of these archaea. The use of culture-indepen-
dent methods has revealed the high proportion of methanogens
[11] that may comprise up to 10% of all anaerobes in the colons of
healthy adults [3,11,20,21]. In addition, although methanogens
are usually found in 30–50% of Western populations [19,22], we
believe that these proportions are underestimated. Besides, using
our method, M. smithii was detected in 75% (15 out of 20), 80%
(16 out of 20), and 100% (9 out of 9) of the lean, obese, and
anorexic faeces, respectively. Methanobrevibacter associated with
Bacteroides thetaiotaomicron led to weight gain in gnotobiotic mice
[3]. An increase in Methanobrevibacter in obese patients was recently
revealed in a study of obese patients before and after gastric
bypass by comparing them to lean controls [21]. Our results were
in agreement with these previous reports, since our obese group
exhibited more Methanobrevibacter than our lean group (1.72-fold
increase). However, the difference was not significant in our study
(p=0.0883). Surprisingly, the anorexic population showed
significantly more Methanobrevibacter than lean patients
(p=0.0171). One explanation for this result may be that the
development of Methanobrevibacter in anorexia nervosa patients
might be associated with an adaptive attempt towards optimal
exploitation of the very low caloric diet absorbed by these
patients. M. smithii recycles hydrogen in methane, allowing for an
increase in the transformation of nutrients into calories [3]. For
anorexic patients, the increase of Methanobrevibacter can lead to
optimization of food transformation in very low calorie diets.
Another explanation for the increase in Methanobrevibacter is that it
could be related to constipation, which is a common phenomenon
in anorexia nervosa patients. An increase in methane producing-
bacteria has been demonstrated in patients who suffer from
constipation or diverticulosis [23,24].
The Lactobacillus population inhabiting the gut microbiota was
also investigated. In a recent study, we focused on the potential
role of Lactobacillus in animal weight gain [13]. Recently, child
growth was suggested to be associated with Lactobacillus intake
[25,26]. Obese populations typically have higher concentrations of
Lactobacillus than lean (p,0.05) or anorexic (p,0.05) populations
(Figure 4). Due to the high inter-subject variability in Lactobacillus
copy number, only a fraction (8 out of 20) of the obese population
had a higher Lactobacillus copy number than the lean (1 out of 20)
or anorexic (0 out of 9) population. This observation reinforces the
possibility of a role for Lactobacillus in weight gain. This
phenomenon was experimentally confirmed by iterated use of a
growth promoter. Recent work by the Gordon team showed that
specific enzymatic activities of obese individuals were found in
Gram-positive bacteria of the Firmicutes phylum (of which
Lactobacillus belong to) rather than in Bacteroidetes [6].
Interestingly, no or few Lactobacillus were retrieved from the
databank of the analyzed bacteria [7]. The difference in these
results can be explained by the difference of bacterial detection
sensitivity of the methodologies as well as amplification or cloning
bias. Our real time PCR tool is highly sensitive with a bacterial
detection threshold of 10
2 bacteria copies/g of feces. Owing to the
relative paucity of the fragments sequenced from studies that use
clonal Sanger sequencing of 16S rRNA genes [11], the evaluation
of the approximately 10
11 bacteria copies/g of feces remains
superficial by this sequencing method. Therefore, a range of 187
to 1100 fragments sequenced per obese [7] probably does not
allow the detection of bacteria in concentrations lower than 10
7
copies/g of feces (such as the Lactobacillus). A recent study found
major differences in the gut microbiota of Chinese people
Figure 5. Quantification of the archaeon M. smithii species.
Values are means6SD. P value ,0.05 is represented as * and P value .
0.05 is indicated by ‘‘ns’’ for not significant.
doi:10.1371/journal.pone.0007125.g005
Figure 4. Distribution of high Lactobacillus concentrations. The
number of individuals having a high Lactobacillus concentration was 1
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our findings reflect a specific European or French diet.
Conclusion
This is the first study on the human gut microbiota that shown
an increase of Lactobacillus in some obese individuals and an
increase of M. smithii in anorexic patients. Based on these
important findings, the use of microarrays for transcriptomic data
comparison of Lactobacillus and M. smithii gene pool between the
different populations could be an interesting challenge for the
understanding of metabolic activities. However, the purpose of this
work was to provide a useful tool for medical monitoring and
diagnostic. We developed a molecular biology tool for quantifying
the Bacteroidetes, Firmicutes, M. smithii, and Lactobacillus microbial
groups. This tool allowed for the identification of specific patient
microbial communities and the confirmation of a specific profile
related to obesity. Patients suffering from anorexia nervosa had a
profile similar to that of lean individuals. However, the M. smithii
species quantification was higher in anorexic patients. Overall, this
study provides preliminary data that links Lactobacillus levels with
obesity.
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